Other differential considerations include granulomatous diseases (e.g., sarcoidosis, tuberculosis, infections), vitamin D-related disorders, hyperthyroidism, medication effects, FGF23-related disorders, and genetic conditions such as familial hypocalciuric hypercalcemia (FHH) [12]. This evidence concerns the gene FGF23 and sarcoidosis.